nodes	percent_of_prediction	percent_of_DWPC	metapath
Nabilone—Dronabinol—CYP3A4—type 2 diabetes mellitus	0.00401	1	CrCbGaD
Nabilone—CNR2—GPCR downstream signaling—EDNRA—type 2 diabetes mellitus	0.000485	0.00144	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—CCKAR—type 2 diabetes mellitus	0.000482	0.00143	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—MC4R—type 2 diabetes mellitus	0.000475	0.00141	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—ADRA2A—type 2 diabetes mellitus	0.000475	0.00141	CbGpPWpGaD
Nabilone—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000475	0.000721	CcSEcCtD
Nabilone—Nausea—Glipizide—type 2 diabetes mellitus	0.000473	0.000719	CcSEcCtD
Nabilone—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000473	0.000718	CcSEcCtD
Nabilone—CNR2—GPCR downstream signaling—GHRL—type 2 diabetes mellitus	0.000473	0.0014	CbGpPWpGaD
Nabilone—Hypotension—Valsartan—type 2 diabetes mellitus	0.000473	0.000718	CcSEcCtD
Nabilone—Vision blurred—Losartan—type 2 diabetes mellitus	0.000473	0.000718	CcSEcCtD
Nabilone—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000471	0.000716	CcSEcCtD
Nabilone—Constipation—Gliclazide—type 2 diabetes mellitus	0.000471	0.000715	CcSEcCtD
Nabilone—Pain—Gliclazide—type 2 diabetes mellitus	0.000471	0.000715	CcSEcCtD
Nabilone—Tremor—Losartan—type 2 diabetes mellitus	0.00047	0.000714	CcSEcCtD
Nabilone—Rash—Glimepiride—type 2 diabetes mellitus	0.000469	0.000712	CcSEcCtD
Nabilone—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000469	0.000712	CcSEcCtD
Nabilone—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000468	0.000711	CcSEcCtD
Nabilone—Rash—Sitagliptin—type 2 diabetes mellitus	0.000467	0.00071	CcSEcCtD
Nabilone—CNR2—GPCR downstream signaling—CALCA—type 2 diabetes mellitus	0.000467	0.00138	CbGpPWpGaD
Nabilone—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000467	0.000709	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—EDNRB—type 2 diabetes mellitus	0.000467	0.00138	CbGpPWpGaD
Nabilone—Headache—Glimepiride—type 2 diabetes mellitus	0.000466	0.000708	CcSEcCtD
Nabilone—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000465	0.000707	CcSEcCtD
Nabilone—Cough—Irbesartan—type 2 diabetes mellitus	0.000465	0.000706	CcSEcCtD
Nabilone—Headache—Sitagliptin—type 2 diabetes mellitus	0.000464	0.000706	CcSEcCtD
Nabilone—Anaemia—Losartan—type 2 diabetes mellitus	0.000463	0.000704	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000461	0.0007	CcSEcCtD
Nabilone—Agitation—Losartan—type 2 diabetes mellitus	0.000461	0.0007	CcSEcCtD
Nabilone—Tinnitus—Ramipril—type 2 diabetes mellitus	0.000461	0.0007	CcSEcCtD
Nabilone—Hypertension—Irbesartan—type 2 diabetes mellitus	0.00046	0.000699	CcSEcCtD
Nabilone—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000459	0.000697	CcSEcCtD
Nabilone—Flushing—Ramipril—type 2 diabetes mellitus	0.000458	0.000696	CcSEcCtD
Nabilone—Infection—Metformin—type 2 diabetes mellitus	0.000458	0.000695	CcSEcCtD
Nabilone—Insomnia—Valsartan—type 2 diabetes mellitus	0.000458	0.000695	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—GIP—type 2 diabetes mellitus	0.000457	0.00135	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—MTNR1B—type 2 diabetes mellitus	0.000456	0.00135	CbGpPWpGaD
Nabilone—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000456	0.000692	CcSEcCtD
Nabilone—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000454	0.00069	CcSEcCtD
Nabilone—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000454	0.000689	CcSEcCtD
Nabilone—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000454	0.000689	CcSEcCtD
Nabilone—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000454	0.000689	CcSEcCtD
Nabilone—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000454	0.000689	CcSEcCtD
Nabilone—Shock—Metformin—type 2 diabetes mellitus	0.000453	0.000689	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—HTR2C—type 2 diabetes mellitus	0.000453	0.00134	CbGpPWpGaD
Nabilone—Insomnia—Orlistat—type 2 diabetes mellitus	0.000452	0.000687	CcSEcCtD
Nabilone—Malaise—Losartan—type 2 diabetes mellitus	0.000452	0.000687	CcSEcCtD
Nabilone—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000452	0.000687	CcSEcCtD
Nabilone—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000452	0.000686	CcSEcCtD
Nabilone—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000451	0.000685	CcSEcCtD
Nabilone—Vertigo—Losartan—type 2 diabetes mellitus	0.000451	0.000684	CcSEcCtD
Nabilone—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.00045	0.000684	CcSEcCtD
Nabilone—Somnolence—Valsartan—type 2 diabetes mellitus	0.00045	0.000683	CcSEcCtD
Nabilone—Syncope—Losartan—type 2 diabetes mellitus	0.00045	0.000683	CcSEcCtD
Nabilone—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000449	0.000682	CcSEcCtD
Nabilone—Leukopenia—Losartan—type 2 diabetes mellitus	0.000449	0.000682	CcSEcCtD
Nabilone—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000448	0.000681	CcSEcCtD
Nabilone—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000445	0.000677	CcSEcCtD
Nabilone—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000445	0.000677	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—GLP1R—type 2 diabetes mellitus	0.000445	0.00132	CbGpPWpGaD
Nabilone—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000444	0.000674	CcSEcCtD
Nabilone—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000444	0.000674	CcSEcCtD
Nabilone—Palpitations—Losartan—type 2 diabetes mellitus	0.000443	0.000673	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—GCGR—type 2 diabetes mellitus	0.000443	0.00131	CbGpPWpGaD
Nabilone—Nausea—Glimepiride—type 2 diabetes mellitus	0.000442	0.000671	CcSEcCtD
Nabilone—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000441	0.00067	CcSEcCtD
Nabilone—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000441	0.000669	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—EDNRA—type 2 diabetes mellitus	0.000441	0.0013	CbGpPWpGaD
Nabilone—Nausea—Sitagliptin—type 2 diabetes mellitus	0.00044	0.000669	CcSEcCtD
Nabilone—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.00044	0.000669	CcSEcCtD
Nabilone—Asthenia—Glyburide—type 2 diabetes mellitus	0.00044	0.000669	CcSEcCtD
Nabilone—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.00044	0.000668	CcSEcCtD
Nabilone—Anorexia—Metformin—type 2 diabetes mellitus	0.000439	0.000667	CcSEcCtD
Nabilone—Cough—Losartan—type 2 diabetes mellitus	0.000438	0.000665	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—CCKAR—type 2 diabetes mellitus	0.000437	0.0013	CbGpPWpGaD
Nabilone—Fatigue—Valsartan—type 2 diabetes mellitus	0.000436	0.000663	CcSEcCtD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—CCL2—type 2 diabetes mellitus	0.000436	0.00129	CbGpPWpGaD
Nabilone—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000435	0.000661	CcSEcCtD
Nabilone—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000435	0.000661	CcSEcCtD
Nabilone—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000435	0.00066	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—LEPR—type 2 diabetes mellitus	0.000435	0.00129	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—CCR5—type 2 diabetes mellitus	0.000434	0.00129	CbGpPWpGaD
Nabilone—Pruritus—Glyburide—type 2 diabetes mellitus	0.000434	0.000659	CcSEcCtD
Nabilone—CNR1—GPCR downstream signaling—IAPP—type 2 diabetes mellitus	0.000434	0.00128	CbGpPWpGaD
Nabilone—Constipation—Valsartan—type 2 diabetes mellitus	0.000433	0.000657	CcSEcCtD
Nabilone—CNR2—GPCR downstream signaling—GCG—type 2 diabetes mellitus	0.000432	0.00128	CbGpPWpGaD
Nabilone—Infection—Irbesartan—type 2 diabetes mellitus	0.000432	0.000656	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—ADRA2A—type 2 diabetes mellitus	0.000431	0.00128	CbGpPWpGaD
Nabilone—Fatigue—Orlistat—type 2 diabetes mellitus	0.000431	0.000655	CcSEcCtD
Nabilone—Hypotension—Metformin—type 2 diabetes mellitus	0.000431	0.000654	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—GHRL—type 2 diabetes mellitus	0.000429	0.00127	CbGpPWpGaD
Nabilone—Shock—Irbesartan—type 2 diabetes mellitus	0.000428	0.00065	CcSEcCtD
Nabilone—Pain—Orlistat—type 2 diabetes mellitus	0.000428	0.00065	CcSEcCtD
Nabilone—Chest pain—Losartan—type 2 diabetes mellitus	0.000427	0.000649	CcSEcCtD
Nabilone—Arthralgia—Losartan—type 2 diabetes mellitus	0.000427	0.000649	CcSEcCtD
Nabilone—Myalgia—Losartan—type 2 diabetes mellitus	0.000427	0.000649	CcSEcCtD
Nabilone—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000427	0.000648	CcSEcCtD
Nabilone—CNR2—GPCR downstream signaling—RASGRP1—type 2 diabetes mellitus	0.000425	0.00126	CbGpPWpGaD
Nabilone—Anxiety—Losartan—type 2 diabetes mellitus	0.000425	0.000646	CcSEcCtD
Nabilone—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000424	0.000645	CcSEcCtD
Nabilone—CNR1—GPCR ligand binding—C3—type 2 diabetes mellitus	0.000424	0.00126	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—CALCA—type 2 diabetes mellitus	0.000424	0.00126	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—TRPC6—type 2 diabetes mellitus	0.000423	0.00125	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—CCL2—type 2 diabetes mellitus	0.000423	0.00125	CbGpPWpGaD
Nabilone—Rash—Bromocriptine—type 2 diabetes mellitus	0.000423	0.000643	CcSEcCtD
Nabilone—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000423	0.000642	CcSEcCtD
Nabilone—Tension—Ramipril—type 2 diabetes mellitus	0.000422	0.000641	CcSEcCtD
Nabilone—Discomfort—Losartan—type 2 diabetes mellitus	0.000422	0.000641	CcSEcCtD
Nabilone—CNR1—GPCR downstream signaling—AGTR2—type 2 diabetes mellitus	0.000421	0.00125	CbGpPWpGaD
Nabilone—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.00042	0.000639	CcSEcCtD
Nabilone—Headache—Bromocriptine—type 2 diabetes mellitus	0.00042	0.000639	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.00042	0.000638	CcSEcCtD
Nabilone—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.00042	0.000638	CcSEcCtD
Nabilone—Nervousness—Ramipril—type 2 diabetes mellitus	0.000418	0.000634	CcSEcCtD
Nabilone—Dry mouth—Losartan—type 2 diabetes mellitus	0.000418	0.000634	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	0.000415	0.00123	CbGpPWpGaD
Nabilone—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000415	0.00063	CcSEcCtD
Nabilone—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000414	0.000629	CcSEcCtD
Nabilone—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000414	0.000629	CcSEcCtD
Nabilone—Confusional state—Losartan—type 2 diabetes mellitus	0.000413	0.000627	CcSEcCtD
Nabilone—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000412	0.000626	CcSEcCtD
Nabilone—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000411	0.000624	CcSEcCtD
Nabilone—Somnolence—Metformin—type 2 diabetes mellitus	0.00041	0.000622	CcSEcCtD
Nabilone—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000409	0.000621	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—GRK5—type 2 diabetes mellitus	0.000408	0.00121	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—GIPR—type 2 diabetes mellitus	0.000408	0.00121	CbGpPWpGaD
Nabilone—Infection—Losartan—type 2 diabetes mellitus	0.000407	0.000618	CcSEcCtD
Nabilone—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000406	0.000617	CcSEcCtD
Nabilone—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000406	0.000616	CcSEcCtD
Nabilone—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000406	0.000616	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—TLE4—type 2 diabetes mellitus	0.000404	0.0012	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—EDNRB—type 2 diabetes mellitus	0.000403	0.00119	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—AGT—type 2 diabetes mellitus	0.000403	0.00119	CbGpPWpGaD
Nabilone—Tremor—Ramipril—type 2 diabetes mellitus	0.000403	0.000612	CcSEcCtD
Nabilone—Shock—Losartan—type 2 diabetes mellitus	0.000403	0.000612	CcSEcCtD
Nabilone—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000401	0.000609	CcSEcCtD
Nabilone—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.0004	0.000608	CcSEcCtD
Nabilone—Tachycardia—Losartan—type 2 diabetes mellitus	0.000399	0.000607	CcSEcCtD
Nabilone—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.000399	0.000606	CcSEcCtD
Nabilone—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000399	0.000605	CcSEcCtD
Nabilone—Fatigue—Metformin—type 2 diabetes mellitus	0.000397	0.000604	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000396	0.000602	CcSEcCtD
Nabilone—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000396	0.000601	CcSEcCtD
Nabilone—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000395	0.0006	CcSEcCtD
Nabilone—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000395	0.0006	CcSEcCtD
Nabilone—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000395	0.0006	CcSEcCtD
Nabilone—Agitation—Ramipril—type 2 diabetes mellitus	0.000395	0.0006	CcSEcCtD
Nabilone—Constipation—Metformin—type 2 diabetes mellitus	0.000394	0.000599	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—IAPP—type 2 diabetes mellitus	0.000394	0.00117	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—GCG—type 2 diabetes mellitus	0.000393	0.00116	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—HTR2C—type 2 diabetes mellitus	0.000391	0.00116	CbGpPWpGaD
Nabilone—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.00039	0.000593	CcSEcCtD
Nabilone—Anorexia—Losartan—type 2 diabetes mellitus	0.00039	0.000593	CcSEcCtD
Nabilone—Vomiting—Glyburide—type 2 diabetes mellitus	0.00039	0.000592	CcSEcCtD
Nabilone—Pruritus—Gliclazide—type 2 diabetes mellitus	0.00039	0.000592	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—ADRB3—type 2 diabetes mellitus	0.000389	0.00115	CbGpPWpGaD
Nabilone—Malaise—Ramipril—type 2 diabetes mellitus	0.000388	0.000589	CcSEcCtD
Nabilone—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000388	0.000589	CcSEcCtD
Nabilone—Rash—Glyburide—type 2 diabetes mellitus	0.000387	0.000587	CcSEcCtD
Nabilone—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000387	0.000587	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	0.000386	0.00114	CbGpPWpGaD
Nabilone—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000386	0.000587	CcSEcCtD
Nabilone—Vertigo—Ramipril—type 2 diabetes mellitus	0.000386	0.000587	CcSEcCtD
Nabilone—Syncope—Ramipril—type 2 diabetes mellitus	0.000386	0.000586	CcSEcCtD
Nabilone—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000385	0.000585	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—TRPC6—type 2 diabetes mellitus	0.000385	0.00114	CbGpPWpGaD
Nabilone—Headache—Glyburide—type 2 diabetes mellitus	0.000384	0.000584	CcSEcCtD
Nabilone—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000383	0.000581	CcSEcCtD
Nabilone—Hypotension—Losartan—type 2 diabetes mellitus	0.000382	0.000581	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—AGTR2—type 2 diabetes mellitus	0.000382	0.00113	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—EDNRA—type 2 diabetes mellitus	0.000381	0.00113	CbGpPWpGaD
Nabilone—Palpitations—Ramipril—type 2 diabetes mellitus	0.00038	0.000577	CcSEcCtD
Nabilone—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.00038	0.000577	CcSEcCtD
Nabilone—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000378	0.000574	CcSEcCtD
Nabilone—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000378	0.000574	CcSEcCtD
Nabilone—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000377	0.000572	CcSEcCtD
Nabilone—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000377	0.000572	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—CRHR1—type 2 diabetes mellitus	0.000376	0.00111	CbGpPWpGaD
Nabilone—Cough—Ramipril—type 2 diabetes mellitus	0.000375	0.00057	CcSEcCtD
Nabilone—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000375	0.00057	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000373	0.000566	CcSEcCtD
Nabilone—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000373	0.000566	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—MC4R—type 2 diabetes mellitus	0.000373	0.0011	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	0.000373	0.0011	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—ADRA2A—type 2 diabetes mellitus	0.000373	0.0011	CbGpPWpGaD
Nabilone—Convulsion—Ramipril—type 2 diabetes mellitus	0.000373	0.000566	CcSEcCtD
Nabilone—Constipation—Irbesartan—type 2 diabetes mellitus	0.000372	0.000565	CcSEcCtD
Nabilone—Pain—Irbesartan—type 2 diabetes mellitus	0.000372	0.000565	CcSEcCtD
Nabilone—CNR1—GPCR downstream signaling—GHRL—type 2 diabetes mellitus	0.000371	0.0011	CbGpPWpGaD
Nabilone—Insomnia—Losartan—type 2 diabetes mellitus	0.00037	0.000562	CcSEcCtD
Nabilone—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000368	0.00056	CcSEcCtD
Nabilone—CNR2—GPCR downstream signaling—AVP—type 2 diabetes mellitus	0.000368	0.00109	CbGpPWpGaD
Nabilone—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000367	0.000558	CcSEcCtD
Nabilone—CNR1—GPCR downstream signaling—CALCA—type 2 diabetes mellitus	0.000367	0.00109	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—EDNRB—type 2 diabetes mellitus	0.000366	0.00108	CbGpPWpGaD
Nabilone—Myalgia—Ramipril—type 2 diabetes mellitus	0.000366	0.000556	CcSEcCtD
Nabilone—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000366	0.000556	CcSEcCtD
Nabilone—Chest pain—Ramipril—type 2 diabetes mellitus	0.000366	0.000556	CcSEcCtD
Nabilone—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000365	0.000554	CcSEcCtD
Nabilone—Anxiety—Ramipril—type 2 diabetes mellitus	0.000365	0.000554	CcSEcCtD
Nabilone—Nausea—Glyburide—type 2 diabetes mellitus	0.000364	0.000553	CcSEcCtD
Nabilone—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000364	0.000553	CcSEcCtD
Nabilone—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000364	0.000553	CcSEcCtD
Nabilone—Somnolence—Losartan—type 2 diabetes mellitus	0.000364	0.000553	CcSEcCtD
Nabilone—Asthenia—Valsartan—type 2 diabetes mellitus	0.000363	0.000552	CcSEcCtD
Nabilone—Discomfort—Ramipril—type 2 diabetes mellitus	0.000362	0.000549	CcSEcCtD
Nabilone—Dyspepsia—Losartan—type 2 diabetes mellitus	0.00036	0.000547	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—GIP—type 2 diabetes mellitus	0.000359	0.00106	CbGpPWpGaD
Nabilone—Asthenia—Orlistat—type 2 diabetes mellitus	0.000359	0.000545	CcSEcCtD
Nabilone—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000358	0.000544	CcSEcCtD
Nabilone—Pruritus—Valsartan—type 2 diabetes mellitus	0.000358	0.000544	CcSEcCtD
Nabilone—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000358	0.000544	CcSEcCtD
Nabilone—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000356	0.00054	CcSEcCtD
Nabilone—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000356	0.00054	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—HTR2C—type 2 diabetes mellitus	0.000355	0.00105	CbGpPWpGaD
Nabilone—Confusional state—Ramipril—type 2 diabetes mellitus	0.000354	0.000537	CcSEcCtD
Nabilone—Pruritus—Orlistat—type 2 diabetes mellitus	0.000354	0.000537	CcSEcCtD
Nabilone—Fatigue—Losartan—type 2 diabetes mellitus	0.000353	0.000536	CcSEcCtD
Nabilone—Vomiting—Gliclazide—type 2 diabetes mellitus	0.00035	0.000532	CcSEcCtD
Nabilone—Pain—Losartan—type 2 diabetes mellitus	0.00035	0.000532	CcSEcCtD
Nabilone—Constipation—Losartan—type 2 diabetes mellitus	0.00035	0.000532	CcSEcCtD
Nabilone—CNR2—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	0.00035	0.00104	CbGpPWpGaD
Nabilone—Rash—Gliclazide—type 2 diabetes mellitus	0.000347	0.000528	CcSEcCtD
Nabilone—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000347	0.000527	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	0.000347	0.00103	CbGpPWpGaD
Nabilone—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000346	0.000526	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—EDNRA—type 2 diabetes mellitus	0.000346	0.00102	CbGpPWpGaD
Nabilone—Shock—Ramipril—type 2 diabetes mellitus	0.000345	0.000524	CcSEcCtD
Nabilone—Headache—Gliclazide—type 2 diabetes mellitus	0.000345	0.000524	CcSEcCtD
Nabilone—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000344	0.000522	CcSEcCtD
Nabilone—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000344	0.000522	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—SPRY2—type 2 diabetes mellitus	0.000343	0.00102	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	0.000343	0.00102	CbGpPWpGaD
Nabilone—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000342	0.00052	CcSEcCtD
Nabilone—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000342	0.00052	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—LEPR—type 2 diabetes mellitus	0.000341	0.00101	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—GCG—type 2 diabetes mellitus	0.000339	0.00101	CbGpPWpGaD
Nabilone—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000339	0.000515	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—GNB3—type 2 diabetes mellitus	0.000339	0.001	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—ADRA2A—type 2 diabetes mellitus	0.000338	0.001	CbGpPWpGaD
Nabilone—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000337	0.000512	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—GHRL—type 2 diabetes mellitus	0.000337	0.000998	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—RBP4—type 2 diabetes mellitus	0.000335	0.000991	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—GLP1R—type 2 diabetes mellitus	0.000335	0.000991	CbGpPWpGaD
Nabilone—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000335	0.000508	CcSEcCtD
Nabilone—Dizziness—Valsartan—type 2 diabetes mellitus	0.000335	0.000508	CcSEcCtD
Nabilone—Anorexia—Ramipril—type 2 diabetes mellitus	0.000335	0.000508	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—MMP3—type 2 diabetes mellitus	0.000334	0.000989	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—AVP—type 2 diabetes mellitus	0.000334	0.000989	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—RASGRP1—type 2 diabetes mellitus	0.000334	0.000989	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—CALCA—type 2 diabetes mellitus	0.000333	0.000986	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—AKT1—type 2 diabetes mellitus	0.000332	0.000985	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	0.000332	0.000984	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—CCL2—type 2 diabetes mellitus	0.000332	0.000983	CbGpPWpGaD
Nabilone—Dizziness—Orlistat—type 2 diabetes mellitus	0.000331	0.000502	CcSEcCtD
Nabilone—Asthenia—Metformin—type 2 diabetes mellitus	0.000331	0.000502	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—CCKAR—type 2 diabetes mellitus	0.000329	0.000975	CbGpPWpGaD
Nabilone—Hypotension—Ramipril—type 2 diabetes mellitus	0.000328	0.000498	CcSEcCtD
Nabilone—Nausea—Gliclazide—type 2 diabetes mellitus	0.000327	0.000497	CcSEcCtD
Nabilone—Pruritus—Metformin—type 2 diabetes mellitus	0.000326	0.000495	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	0.000326	0.000965	CbGpPWpGaD
Nabilone—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000324	0.000491	CcSEcCtD
Nabilone—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000324	0.000491	CcSEcCtD
Nabilone—Vomiting—Valsartan—type 2 diabetes mellitus	0.000322	0.000489	CcSEcCtD
Nabilone—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.00032	0.000487	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.00032	0.000486	CcSEcCtD
Nabilone—Rash—Valsartan—type 2 diabetes mellitus	0.000319	0.000485	CcSEcCtD
Nabilone—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000319	0.000484	CcSEcCtD
Nabilone—Vomiting—Orlistat—type 2 diabetes mellitus	0.000318	0.000483	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—EDN1—type 2 diabetes mellitus	0.000318	0.000941	CbGpPWpGaD
Nabilone—Insomnia—Ramipril—type 2 diabetes mellitus	0.000317	0.000482	CcSEcCtD
Nabilone—Headache—Valsartan—type 2 diabetes mellitus	0.000317	0.000482	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—TLE4—type 2 diabetes mellitus	0.000317	0.000939	CbGpPWpGaD
Nabilone—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000315	0.000479	CcSEcCtD
Nabilone—Rash—Orlistat—type 2 diabetes mellitus	0.000315	0.000479	CcSEcCtD
Nabilone—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000315	0.000479	CcSEcCtD
Nabilone—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000315	0.000478	CcSEcCtD
Nabilone—Headache—Orlistat—type 2 diabetes mellitus	0.000313	0.000476	CcSEcCtD
Nabilone—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000313	0.000475	CcSEcCtD
Nabilone—CNR2—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	0.000313	0.000926	CbGpPWpGaD
Nabilone—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000312	0.000474	CcSEcCtD
Nabilone—Somnolence—Ramipril—type 2 diabetes mellitus	0.000312	0.000474	CcSEcCtD
Nabilone—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000309	0.000469	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—GCG—type 2 diabetes mellitus	0.000308	0.000913	CbGpPWpGaD
Nabilone—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000308	0.000467	CcSEcCtD
Nabilone—CNR2—GPCR downstream signaling—C3—type 2 diabetes mellitus	0.000306	0.000905	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—ADRB3—type 2 diabetes mellitus	0.000305	0.000904	CbGpPWpGaD
Nabilone—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000305	0.000463	CcSEcCtD
Nabilone—Dizziness—Metformin—type 2 diabetes mellitus	0.000305	0.000463	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	0.000303	0.000898	CbGpPWpGaD
Nabilone—Fatigue—Ramipril—type 2 diabetes mellitus	0.000303	0.00046	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	0.000302	0.000894	CbGpPWpGaD
Nabilone—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000302	0.000458	CcSEcCtD
Nabilone—Nausea—Valsartan—type 2 diabetes mellitus	0.000301	0.000457	CcSEcCtD
Nabilone—Constipation—Ramipril—type 2 diabetes mellitus	0.0003	0.000456	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	0.000298	0.000884	CbGpPWpGaD
Nabilone—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000298	0.000452	CcSEcCtD
Nabilone—Nausea—Orlistat—type 2 diabetes mellitus	0.000297	0.000451	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—IAPP—type 2 diabetes mellitus	0.000296	0.000878	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—INSR—type 2 diabetes mellitus	0.000295	0.000873	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CRHR1—type 2 diabetes mellitus	0.000295	0.000873	CbGpPWpGaD
Nabilone—Asthenia—Losartan—type 2 diabetes mellitus	0.000294	0.000446	CcSEcCtD
Nabilone—Vomiting—Metformin—type 2 diabetes mellitus	0.000293	0.000445	CcSEcCtD
Nabilone—CNR1—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	0.000293	0.000866	CbGpPWpGaD
Nabilone—Rash—Metformin—type 2 diabetes mellitus	0.000291	0.000441	CcSEcCtD
Nabilone—CNR2—GPCR downstream signaling—AGT—type 2 diabetes mellitus	0.00029	0.00086	CbGpPWpGaD
Nabilone—Dermatitis—Metformin—type 2 diabetes mellitus	0.00029	0.000441	CcSEcCtD
Nabilone—Pruritus—Losartan—type 2 diabetes mellitus	0.00029	0.00044	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—TRPC6—type 2 diabetes mellitus	0.000289	0.000857	CbGpPWpGaD
Nabilone—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000289	0.000439	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	0.000289	0.000856	CbGpPWpGaD
Nabilone—Headache—Metformin—type 2 diabetes mellitus	0.000289	0.000439	CcSEcCtD
Nabilone—CNR1—GPCR downstream signaling—AVP—type 2 diabetes mellitus	0.000289	0.000855	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—AGTR2—type 2 diabetes mellitus	0.000288	0.000852	CbGpPWpGaD
Nabilone—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000288	0.000437	CcSEcCtD
Nabilone—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000287	0.000436	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—CCR5—type 2 diabetes mellitus	0.000284	0.000841	CbGpPWpGaD
Nabilone—Diarrhoea—Losartan—type 2 diabetes mellitus	0.00028	0.000425	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—C3—type 2 diabetes mellitus	0.000277	0.000822	CbGpPWpGaD
Nabilone—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000277	0.000421	CcSEcCtD
Nabilone—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000277	0.000421	CcSEcCtD
Nabilone—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000276	0.00042	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—EDNRB—type 2 diabetes mellitus	0.000276	0.000816	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	0.000274	0.000813	CbGpPWpGaD
Nabilone—Rash—Irbesartan—type 2 diabetes mellitus	0.000274	0.000417	CcSEcCtD
Nabilone—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000274	0.000416	CcSEcCtD
Nabilone—Nausea—Metformin—type 2 diabetes mellitus	0.000274	0.000416	CcSEcCtD
Nabilone—Headache—Irbesartan—type 2 diabetes mellitus	0.000272	0.000414	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	0.000272	0.000805	CbGpPWpGaD
Nabilone—Dizziness—Losartan—type 2 diabetes mellitus	0.000271	0.000411	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—SPRY2—type 2 diabetes mellitus	0.00027	0.000798	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	0.00027	0.000798	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	0.000268	0.000794	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—HTR2C—type 2 diabetes mellitus	0.000268	0.000792	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PSMD6—type 2 diabetes mellitus	0.000268	0.000792	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—GNB3—type 2 diabetes mellitus	0.000266	0.000787	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—AGT—type 2 diabetes mellitus	0.000264	0.000781	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—RBP4—type 2 diabetes mellitus	0.000263	0.000778	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—GLP1R—type 2 diabetes mellitus	0.000263	0.000778	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—AVP—type 2 diabetes mellitus	0.000262	0.000776	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—MMP3—type 2 diabetes mellitus	0.000262	0.000776	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	0.000261	0.000772	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—EDNRA—type 2 diabetes mellitus	0.00026	0.000771	CbGpPWpGaD
Nabilone—Vomiting—Losartan—type 2 diabetes mellitus	0.00026	0.000395	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—CALM1—type 2 diabetes mellitus	0.000259	0.000768	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CYBA—type 2 diabetes mellitus	0.000259	0.000767	CbGpPWpGaD
Nabilone—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000259	0.000393	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—CCKAR—type 2 diabetes mellitus	0.000258	0.000765	CbGpPWpGaD
Nabilone—Nausea—Irbesartan—type 2 diabetes mellitus	0.000258	0.000392	CcSEcCtD
Nabilone—Rash—Losartan—type 2 diabetes mellitus	0.000258	0.000392	CcSEcCtD
Nabilone—Dermatitis—Losartan—type 2 diabetes mellitus	0.000258	0.000392	CcSEcCtD
Nabilone—Headache—Losartan—type 2 diabetes mellitus	0.000256	0.000389	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	0.000255	0.000754	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PLAT—type 2 diabetes mellitus	0.000254	0.000751	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—GHRL—type 2 diabetes mellitus	0.000254	0.000751	CbGpPWpGaD
Nabilone—Asthenia—Ramipril—type 2 diabetes mellitus	0.000252	0.000382	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—CALCA—type 2 diabetes mellitus	0.000251	0.000742	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—EDN1—type 2 diabetes mellitus	0.000249	0.000738	CbGpPWpGaD
Nabilone—Pruritus—Ramipril—type 2 diabetes mellitus	0.000248	0.000377	CcSEcCtD
Nabilone—CNR1—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	0.000245	0.000727	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	0.000244	0.000721	CbGpPWpGaD
Nabilone—Nausea—Losartan—type 2 diabetes mellitus	0.000243	0.000369	CcSEcCtD
Nabilone—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.00024	0.000365	CcSEcCtD
Nabilone—CNR1—GPCR downstream signaling—C3—type 2 diabetes mellitus	0.00024	0.00071	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	0.000237	0.000701	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	0.000236	0.000699	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	0.000235	0.000696	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	0.000234	0.000693	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—IAPP—type 2 diabetes mellitus	0.000233	0.000689	CbGpPWpGaD
Nabilone—Dizziness—Ramipril—type 2 diabetes mellitus	0.000232	0.000353	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—GCG—type 2 diabetes mellitus	0.000232	0.000687	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PTPN1—type 2 diabetes mellitus	0.000232	0.000687	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—INSR—type 2 diabetes mellitus	0.000231	0.000685	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	0.000228	0.000676	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—AGT—type 2 diabetes mellitus	0.000228	0.000675	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	0.000228	0.000674	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—TRPC6—type 2 diabetes mellitus	0.000227	0.000673	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	0.000227	0.000672	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—AGTR2—type 2 diabetes mellitus	0.000226	0.000669	CbGpPWpGaD
Nabilone—Vomiting—Ramipril—type 2 diabetes mellitus	0.000223	0.000339	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—CCR5—type 2 diabetes mellitus	0.000223	0.00066	CbGpPWpGaD
Nabilone—Rash—Ramipril—type 2 diabetes mellitus	0.000221	0.000336	CcSEcCtD
Nabilone—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000221	0.000336	CcSEcCtD
Nabilone—Headache—Ramipril—type 2 diabetes mellitus	0.00022	0.000334	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—C3—type 2 diabetes mellitus	0.000218	0.000645	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—CCL2—type 2 diabetes mellitus	0.000217	0.000643	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—EDNRB—type 2 diabetes mellitus	0.000216	0.000641	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—AKT2—type 2 diabetes mellitus	0.000213	0.000632	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	0.000213	0.000631	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	0.000211	0.000623	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PSMD6—type 2 diabetes mellitus	0.00021	0.000622	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—HTR2C—type 2 diabetes mellitus	0.00021	0.000622	CbGpPWpGaD
Nabilone—Nausea—Ramipril—type 2 diabetes mellitus	0.000208	0.000317	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—AGT—type 2 diabetes mellitus	0.000207	0.000613	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	0.000204	0.000605	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—CALM1—type 2 diabetes mellitus	0.000203	0.000602	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CYBA—type 2 diabetes mellitus	0.000203	0.000602	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	0.000202	0.000598	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—GNB3—type 2 diabetes mellitus	0.0002	0.000592	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	0.0002	0.000592	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PLAT—type 2 diabetes mellitus	0.000199	0.000589	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—GHRL—type 2 diabetes mellitus	0.000199	0.000589	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—AVP—type 2 diabetes mellitus	0.000197	0.000584	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—MMP3—type 2 diabetes mellitus	0.000197	0.000584	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CALCA—type 2 diabetes mellitus	0.000197	0.000582	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—IGF2—type 2 diabetes mellitus	0.000196	0.000582	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	0.000196	0.000579	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	0.000194	0.000573	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	0.000191	0.000566	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—APOB—type 2 diabetes mellitus	0.000191	0.000565	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	0.00019	0.000562	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—EDN1—type 2 diabetes mellitus	0.000188	0.000556	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	0.000185	0.000548	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	0.000184	0.000546	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—LPL—type 2 diabetes mellitus	0.000182	0.000539	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	0.000182	0.000539	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—GCG—type 2 diabetes mellitus	0.000182	0.000539	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	0.000179	0.00053	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	0.000179	0.000529	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	0.000178	0.000528	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	0.000171	0.000506	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	0.00017	0.000505	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CCR5—type 2 diabetes mellitus	0.000168	0.000497	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	0.000167	0.000496	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	0.000167	0.000495	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—C3—type 2 diabetes mellitus	0.000164	0.000485	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	0.000158	0.000469	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—GNB3—type 2 diabetes mellitus	0.000157	0.000465	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	0.000156	0.000463	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—IRS2—type 2 diabetes mellitus	0.000156	0.000462	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—AGT—type 2 diabetes mellitus	0.000156	0.000461	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—AVP—type 2 diabetes mellitus	0.000155	0.000458	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MMP3—type 2 diabetes mellitus	0.000155	0.000458	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—IGF2—type 2 diabetes mellitus	0.000154	0.000456	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	0.000153	0.000454	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CALM1—type 2 diabetes mellitus	0.000153	0.000454	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—APOE—type 2 diabetes mellitus	0.000153	0.000452	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—LEP—type 2 diabetes mellitus	0.000153	0.000452	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	0.000152	0.00045	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—APOA1—type 2 diabetes mellitus	0.000151	0.000447	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—APOB—type 2 diabetes mellitus	0.00015	0.000443	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	0.000149	0.000441	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—EDN1—type 2 diabetes mellitus	0.000147	0.000436	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	0.000144	0.000426	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—LPL—type 2 diabetes mellitus	0.000143	0.000423	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	0.00014	0.000414	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—IRS1—type 2 diabetes mellitus	0.000136	0.000403	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	0.000134	0.000397	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CCR5—type 2 diabetes mellitus	0.000132	0.00039	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—INS—type 2 diabetes mellitus	0.00013	0.000386	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—C3—type 2 diabetes mellitus	0.000129	0.000381	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CCL2—type 2 diabetes mellitus	0.000128	0.00038	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—IGF1—type 2 diabetes mellitus	0.000126	0.000373	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—AKT2—type 2 diabetes mellitus	0.000126	0.000373	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	0.000125	0.000372	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	0.000123	0.000363	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—IRS2—type 2 diabetes mellitus	0.000122	0.000362	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—AGT—type 2 diabetes mellitus	0.000122	0.000362	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CALM1—type 2 diabetes mellitus	0.00012	0.000356	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	0.00012	0.000355	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—LEP—type 2 diabetes mellitus	0.00012	0.000355	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—APOE—type 2 diabetes mellitus	0.00012	0.000355	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—APOA1—type 2 diabetes mellitus	0.000118	0.000351	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	0.000114	0.000339	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—NOS3—type 2 diabetes mellitus	0.000114	0.000339	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	0.000113	0.000334	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—RELA—type 2 diabetes mellitus	0.000108	0.000319	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—IRS1—type 2 diabetes mellitus	0.000107	0.000316	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—INS—type 2 diabetes mellitus	0.000102	0.000303	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CCL2—type 2 diabetes mellitus	0.000101	0.000298	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—IGF1—type 2 diabetes mellitus	9.9e-05	0.000293	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—AKT2—type 2 diabetes mellitus	9.89e-05	0.000293	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	9.85e-05	0.000292	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	9.8e-05	0.00029	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CASP3—type 2 diabetes mellitus	9.71e-05	0.000287	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—IL6—type 2 diabetes mellitus	9.64e-05	0.000286	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	9.4e-05	0.000278	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—MMP9—type 2 diabetes mellitus	9.17e-05	0.000272	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9.08e-05	0.000269	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	8.97e-05	0.000266	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—NOS3—type 2 diabetes mellitus	8.97e-05	0.000266	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	8.9e-05	0.000263	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—SRC—type 2 diabetes mellitus	8.46e-05	0.00025	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—RELA—type 2 diabetes mellitus	8.44e-05	0.00025	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.24e-05	0.000244	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	7.69e-05	0.000228	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CASP3—type 2 diabetes mellitus	7.62e-05	0.000226	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—IL6—type 2 diabetes mellitus	7.57e-05	0.000224	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.56e-05	0.000224	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.41e-05	0.00022	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MMP9—type 2 diabetes mellitus	7.2e-05	0.000213	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	7.12e-05	0.000211	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	6.98e-05	0.000207	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—SRC—type 2 diabetes mellitus	6.64e-05	0.000197	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.46e-05	0.000191	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	5.93e-05	0.000176	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.82e-05	0.000172	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—IL6—type 2 diabetes mellitus	5.7e-05	0.000169	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.26e-05	0.000156	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—IL6—type 2 diabetes mellitus	4.47e-05	0.000132	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.12e-05	0.000122	CbGpPWpGaD
